Related content

PIK3CA mutations in breast cancer are associated with poor outcome

By Li Shao   Rong Minna   Grieu Fabienne   Iacopetta Barry  

Breast Cancer Research and Treatment, Vol. 96, Iss. 1, 2006-03 ,pp. : 91-95

Springer Publishing Company

Access to resources Recommend Favorite

PIK3CA Gene Mutations and Amplifications in Chinese Patients With Ovarian Clear Cell Carcinoma

By Jiang Gaofeng   Huang Zhixiong   Zhang Shuangling   Wang Lin  

Cancer Investigation, Vol. 31, Iss. 10, 2013-12 ,pp. : 639-644

Informa Healthcare

Access to resources Recommend Favorite

Evaluation of the association of PIK3CA mutations and PTEN loss with efficacy of trastuzumab therapy in metastatic breast cancer

By Razis E.  

Breast Cancer Research and Treatment, Vol. 128, Iss. 2, 2011-07 ,pp. : 447-456

Springer Publishing Company

Access to resources Recommend Favorite

PIK3CA Mutations and BRCA1 Expression in Breast Cancer: Potential Biomarkers for Chemoresistance

By Santarpia Mariacarmela   Altavilla Giuseppe   Margeli Mireia   Cirauqui Beatriz   Mesiti Mario   Cavallari Vittorio   Ramirez Jose Luis   Sanchez-Ronco Maria   Santarpia Libero   Taron Miquel   Rosell Rafael  

Cancer Investigation, Vol. 26, Iss. 10, 2008-12 ,pp. : 1044-1051

Informa Healthcare

Access to resources Recommend Favorite

Identification of KRAS and PIK3CA but not BRAF mutations in patients with gastric cancer

By                

Molecular Medicine Reports, Vol. 12, Iss. 1, 2015-01 ,pp. : 1219-1224

Spandidos Publications

Access to resources Recommend Favorite